First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report

Omid Mozafari, Seyed Shorofi, Seyde Yousefi

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).

    Original languageEnglish
    Pages (from-to)1217-1219
    Number of pages3
    JournalIranian Journal of Public Health
    Volume45
    Issue number9
    Publication statusPublished - 2016

    Fingerprint Dive into the research topics of 'First report on infant acute urticaria after mother's parenteral use of meglumine antimoniate (Glucantime): A case report'. Together they form a unique fingerprint.

    Cite this